X4 Pharmaceuticals Inc

-0.16 (-12.02%)
Earnings Announcements

X4 Pharmaceuticals Reports Q2 Loss Per Share Of $0.60

Published: 08/04/2022 11:48 GMT
X4 Pharmaceuticals Inc (XFOR) - X4 Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Corporate Update.
Qtrly Loss per Share $0.60.
Q2 Earnings per Share View $-0.64 -- Refinitiv Ibes Data (analyst estimates).
X4 Had $48.7 Million in Cash, Cash Equivalents, and Restricted Cash As of June 30, 2022.
X4 Believes That It Has Sufficient Funds to Support Company Operations Into Q3 of 2023.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.29

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.31

More details on our Analysts Page.